MD Clarity Named to G2’s 2026 Best Software Awards, Ranking in G2’s Top 50 Across All Healthcare Software Categories
SEATTLE, WA / ACCESS Newswire / February 26, 2026 / MD Clarity, a leading provider of revenue optimization solutions, today...
SEATTLE, WA / ACCESS Newswire / February 26, 2026 / MD Clarity, a leading provider of revenue optimization solutions, today...
Two decades of recognition underscore leadership in clinical innovation, employer strategy NORTHAMPTON, MA / ACCESS Newswire / February 26, 2026...
Ottawa, Ontario--(Newsfile Corp. - February 26, 2026) - New national public opinion research released today by the Canadian Dental Hygienists...
NAPLES, FL / ACCESS Newswire / February 26, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell...
With 20g of clean protein, 5g of creatine, and LactoSpore® probiotics, Empowr supports everyday strength, mental energy and digestive balance...
France country extract from the 2026 Black Book of Global Digital Healthcare IT highlights procurement "proof points" shaping hospital DPI/EHR...
STUDIO CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Every March, the International Myeloma Foundation (IMF) leads Myeloma Action Month...
MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD),...
Pursuing a traditional approval path for bitopertin in erythropoietic protoporphyria (EPP); Phase 3 APOLLO study is expected to complete enrollment...
Surgeons complete initial cases at premier disc replacement centers across the United States. WESTMINSTER, Colo., Feb. 26, 2026 (GLOBE NEWSWIRE)...
THE WOODLANDS, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release...
HOUSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued...
Mark Flather and Dr. Fred Brown join to expand adoption of Derisq™ and Operon™, delivering AI-powered risk prediction and portfolio...
Videos on the NETHERTON NOW website have been viewed 2 million times with 24 million impressions Patients, families, and clinicians...
HOUSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Glow Holdings, Inc. (OTC: GLOH), doing business as GlohCo, an emerging healthtech company...
Accepted Abstract Highlights Metabolic Response Observations Following Chemotherapeutic Drug-Delivery via the TAMP™ Therapy Platform in Patients Diagnosed with Locally Advanced...
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the...
Results from IV Phase 1 SAD/MAD Trial Expected in 2026JERSEY CITY, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc....
Physician Interview Now AvailableKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction...
Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company...